Vaishali Pharma Ltd recommends 1:1 bonus issue and 1:5 stock split
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
The emergence of new infections in India is a growing concern
The robotic surgery program has continually pushed the boundaries of medical technology
India Business grew by 11.9% YoY to Rs. 1196.2 crore
The clinical trial will be conducted at 19 sites with 10,335 participants across India
The partnership marks a significant milestone in integrating digital health education into medical curricula
Subscribe To Our Newsletter & Stay Updated